Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.

Saved in:
Bibliographic Details
Title: Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.
Authors: Hincelin-Mery A; Sanofi, Chilly-Mazarin, France., Nicolas X; Sanofi, Montpellier, France., Cantalloube C; Sanofi, Chilly-Mazarin, France., Pomponio R; Sanofi, Cambridge, Massachusetts, USA., Lewanczyk P; Ividata Life Sciences, Levallois-Perret, France., Benamor M; Sanofi, Chilly-Mazarin, France., Ofengeim D; Sanofi, Cambridge, Massachusetts, USA., Krupka E; Sanofi, Montpellier, France., Hsiao-Nakamoto J; Denali Therapeutics Inc., South San Francisco, California, USA., Eastenson A; Nucleus Network Pty Ltd., St. Paul, Minnesota, USA., Atassi N; Sanofi, Cambridge, Massachusetts, USA.
Source: Clinical and translational science [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13690. Date of Electronic Publication: 2023 Dec 11.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38010108
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hincelin-Mery+A%22">Hincelin-Mery A</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Nicolas+X%22">Nicolas X</searchLink>; Sanofi, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Cantalloube+C%22">Cantalloube C</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Pomponio+R%22">Pomponio R</searchLink>; Sanofi, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lewanczyk+P%22">Lewanczyk P</searchLink>; Ividata Life Sciences, Levallois-Perret, France.<br /><searchLink fieldCode="AU" term="%22Benamor+M%22">Benamor M</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Ofengeim+D%22">Ofengeim D</searchLink>; Sanofi, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Krupka+E%22">Krupka E</searchLink>; Sanofi, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Hsiao-Nakamoto+J%22">Hsiao-Nakamoto J</searchLink>; Denali Therapeutics Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Eastenson+A%22">Eastenson A</searchLink>; Nucleus Network Pty Ltd., St. Paul, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Atassi+N%22">Atassi N</searchLink>; Sanofi, Cambridge, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13690. <i>Date of Electronic Publication: </i>2023 Dec 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38010108
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cts.13690
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e13690
    Titles:
      – TitleFull: Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hincelin-Mery A
      – PersonEntity:
          Name:
            NameFull: Nicolas X
      – PersonEntity:
          Name:
            NameFull: Cantalloube C
      – PersonEntity:
          Name:
            NameFull: Pomponio R
      – PersonEntity:
          Name:
            NameFull: Lewanczyk P
      – PersonEntity:
          Name:
            NameFull: Benamor M
      – PersonEntity:
          Name:
            NameFull: Ofengeim D
      – PersonEntity:
          Name:
            NameFull: Krupka E
      – PersonEntity:
          Name:
            NameFull: Hsiao-Nakamoto J
      – PersonEntity:
          Name:
            NameFull: Eastenson A
      – PersonEntity:
          Name:
            NameFull: Atassi N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1752-8062
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical and translational science
              Type: main
ResultId 1